We are live on
!
Find out more
SCM
Silvant Capital Management Portfolio holdings
AUM
$2.89B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+11.79%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$534M
AUM Growth
-$21.9M
(-3.9%)
Cap. Flow
-$79.4M
Cap. Flow
% of AUM
-14.86%
Top 10 Holdings %
Top 10 Hldgs %
43.67%
Holding
341
New
6
Increased
22
Reduced
97
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Akamai
AKAM
|
+$1M |
| 2 |
Teladoc Health
TDOC
|
+$518K |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$307K |
| 4 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$200K |
| 5 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$179K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$8.63M |
| 2 |
Microsoft
MSFT
|
+$8.52M |
| 3 |
Amazon
AMZN
|
+$7.33M |
| 4 |
Visa
V
|
+$3.3M |
| 5 |
Meta Platforms (Facebook)
META
|
+$3.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Consumer Discretionary | 14.6% |
| 3 | Healthcare | 14.58% |
| 4 | Financials | 11.75% |
| 5 | Communication Services | 11.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Boeing
BA
$171B
| $4.3M | 0.81% |
26,046
-6,585
| -20% | -$1.12M |
|
27
Qualcomm
QCOM
$155B
| $4.16M | 0.78% |
35,330
-5,705
| -14% | -$609K |
|
28
Comcast
CMCSA
$85B
| $4.15M | 0.78% |
89,805
-23,422
| -21% | -$1.02M |
|
29
Estee Lauder
EL
$30.4B
| $4.02M | 0.75% |
18,424
-4,795
| -21% | -$987K |
|
30
McDonald's
MCD
$192B
| $3.93M | 0.73% |
17,886
-1,508
| -8% | -$310K |
|
31
Workday
WDAY
$39.6B
| $3.78M | 0.71% |
17,565
-4,685
| -21% | -$927K |
|
32
JPMorgan Chase
JPM
$935B
| $3.7M | 0.69% |
38,422
-630
| -2% | -$61.9K |
|
33
Republic Services
RSG
$64.8B
| $3.68M | 0.69% |
39,206
-700
| -2% | -$62.6K |
|
34
Medtronic
MDT
$109B
| $3.57M | 0.67% |
34,181
-607
| -2% | -$61K |
|
35
Bank of America
BAC
$435B
| $3.43M | 0.64% |
142,230
-2,448
| -2% | -$60.9K |
|
36
Pfizer
PFE
$143B
| $3.28M | 0.61% |
94,305
-1,391
| -1% | -$48.8K |
|
37
Equinix
EQIX
$101B
| $3.23M | 0.6% |
4,252
-1,123
| -21% | -$850K |
|
38
Applied Materials
AMAT
$403B
| $3.17M | 0.59% |
53,330
-14,016
| -21% | -$866K |
|
39
Texas Instruments
TXN
$252B
| $3.12M | 0.58% |
21,837
-365
| -2% | -$49.6K |
|
40
Domino's
DPZ
$11.5B
| $3.08M | 0.58% |
7,237
-132
| -2% | -$52.6K |
|
41
Vertex Pharmaceuticals
VRTX
$121B
| $3.04M | 0.57% |
11,166
-2,995
| -21% | -$826K |
|
42
Intuitive Surgical
ISRG
$127B
| $3M | 0.56% |
12,699
-3,303
| -21% | -$742K |
|
43
Merck
MRK
$322B
| $2.97M | 0.56% |
37,229
-539
| -1% | -$42.2K |
|
44
Bristol-Myers Squibb
BMY
$133B
| $2.96M | 0.55% |
49,098
-11,615
| -19% | -$699K |
|
45
Mettler-Toledo International
MTD
$28.6B
| $2.92M | 0.55% |
3,023
-806
| -21% | -$748K |
|
46
Deere & Co
DE
$160B
| $2.9M | 0.54% |
13,049
-3,419
| -21% | -$660K |
|
47
CME Group
CME
$96.3B
| $2.88M | 0.54% |
17,243
-296
| -2% | -$49.9K |
|
|
48
Teladoc Health
TDOC
$1.22B
| $2.87M | 0.54% |
13,092
+2,445
| +23% | +$518K |
|
49
Norfolk Southern
NSC
$75.4B
| $2.8M | 0.52% |
13,066
-232
| -2% | -$46.6K |
|
50
Knight Transportation
KNX
$11.3B
| $2.79M | 0.52% |
68,663
-18,065
| -21% | -$793K |
|
Similar funds
AG
NRCM
BAM
PFM
DMIC
LIP
CCM
HCC
Silvant Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Silvant Capital Management held 341 positions worth $534M, down 3.9% from $556M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Silvant Capital Management withdrew a net $79.4M in Q3 2020, closing 12 positions and reducing 97 holdings. Its most notable exit was HealthEquity, an estimated $390K position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Silvant Capital Management opened a new position in Akamai worth $998K.
- Silvant Capital Management's largest Q3 2020 buy was Akamai: 9,024 shares worth $998K.
- Silvant Capital Management added most to Teladoc Health in Q3 2020, an estimated $518K increase.
- Silvant Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $8.63M.
- Silvant Capital Management fully exited HealthEquity in Q3 2020, selling an estimated $390K.
- Silvant Capital Management's ten largest holdings make up 44% of its $534M portfolio in Q3 2020.
- Silvant Capital Management opened 6 new positions and closed 12 in Q3 2020.
- Silvant Capital Management's portfolio value fell 3.9% quarter-over-quarter to $534M.
Based on Silvant Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.